SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.

MLA

Murakami, Shigekazu, et al. “SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.” Stem Cells, vol. 33, no. 9, Sept. 2015, pp. 2652–63. EBSCOhost, https://doi.org/10.1002/stem.2059.

APA

Murakami, S., Ninomiya, W., Sakamoto, E., Shibata, T., Akiyama, H., & Tashiro, F. (2015). SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets. Stem Cells, 33(9), 2652–2663. https://doi.org/10.1002/stem.2059

Chicago

Murakami, Shigekazu, Wataru Ninomiya, Erina Sakamoto, Tatsuhiro Shibata, Hirotada Akiyama, and Fumio Tashiro. 2015. “SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.” Stem Cells 33 (9): 2652–63. doi:10.1002/stem.2059.